Advances in GLP-1 Receptor Agonist Research
Recent studies have demonstrated the multifaceted potential of GLP-1 receptor agonists beyond glucose homeostasis, including cardiovascular benefits and neuroprotective properties.
Pharmaceutical-grade lyophilized compounds for advanced scientific research. ≥98% purity verified by HPLC & Mass Spectrometry.
Curated by purity, stability, and peer-reviewed research coverage.
Every compound we produce undergoes stringent quality assurance — from raw-material verification to final product testing.
≥98% purity verified by HPLC & Mass Spectrometry on every batch.
Every step — from synthesis to packaging — meets pharmaceutical standards.
Stability, extended shelf life, and preserved bioactivity across every compound.
Every batch carries a unique scratch-off code to confirm it's genuine LyoGenix.
Beyond lyophilized vials, LyoGenix offers research-grade pre-filled pen devices for GLP-1, GIP, and triple-agonist compounds — precise multi-dose delivery with no reconstitution required.
No reconstitution
Pre-formulated sterile solution — ready to use.
Multi-dose
Consistent subcutaneous delivery across a research protocol.
Precise dialing
Reproducible dosing for dose-response studies.
Our peptides and delivery systems are organized by research application — explore the three most requested categories below.
New compounds, stability data, and scientific commentary — no noise, unsubscribe anytime.
We respect your privacy. Unsubscribe at any time.